Effects of tart cherry powder on metabolic syndrome
Impact of 60 Days Powdered Tart Cherry Supplementation on Metabolic Syndrome
This study is testing whether taking tart cherry powder can help people with metabolic syndrome improve their heart health and reduce their risk of diabetes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Ohio University Academic / other |
| Locations | 1 site (Athens, Ohio) |
| Trial ID | NCT05614947 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of powdered tart cherry supplementation on individuals diagnosed with metabolic syndrome, a condition linked to increased risk of cardiovascular disease and type II diabetes. Participants will receive either the tart cherry supplement or a placebo over a 60-day period. The study aims to assess changes in metabolic parameters such as lipid levels, glucose clearance, and inflammation markers. By focusing on dietary interventions, the research seeks to explore the potential benefits of polyphenols found in tart cherries on metabolic health.
Who should consider this trial
Good fit: Ideal candidates are adults aged 25-60 who have been diagnosed with metabolic syndrome or meet its diagnostic criteria.
Not a fit: Patients currently taking medications for glucose or lipid control, or those with inflammatory conditions, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a natural dietary supplement option to help manage metabolic syndrome and reduce associated health risks.
How similar studies have performed: While the specific use of tart cherry supplementation is less common, other studies have shown positive effects of polyphenols on metabolic health, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have been diagnosed with metabolic syndrome by a physician or meet the diagnostic criteria: Waist circumference greater than 40 inches (men) or greater than 35 inches (women), High blood pressure (greater than 130/80) or taking medication for high blood pressure, High triglycerides (greater than 150 mg/dL) or low HDL (less than 40 for men, less than 50 for women), High fasting blood glucose (100-126 mg/dL) or diagnosed as pre-diabetic * Age 25-60 Exclusion Criteria: * currently taking medication for glucose or lipid control, such as metformin and/or statin * currently using anti-inflammatory medications \& have not used corticosteroids in the last two months * diagnosed with or currently being treated for an inflammatory condition * major organ system impairment (heart failure, renal failure, severe impairment of respiratory function) * currently a smoker or quit less than 12 months ago
Where this trial is running
Athens, Ohio
- Ohio University Exercise Physiology Lab — Athens, Ohio, United States (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.